Publish in this journal
Journal Information
Vol. 6. Issue 1.
Pages 71 (January - February 2010)
Share
Share
Download PDF
More article options
Vol. 6. Issue 1.
Pages 71 (January - February 2010)
DOI: 10.1016/S2173-5743(10)70015-0
Full text access
Ageusia associated to treatment with pregabalin
Ageusia asociada a tratamiento con pregabalina
Visits
...
Victor González Vallés, Javier Calvo Catalá
Corresponding author
calvo_jav@gva.es

Corresponding author.
, Cristina Campos Fernández, Amalia Rueda Cid
Unidad de Reumatología y Metabolismo Óseo, Consorcio Hospital General Universitario, Valencia, Spain
Article information
Bibliography
Download PDF
Statistics
Full text is only aviable in PDF
References
[1.]
I.W. Tremon-Lukaats, C. Megeff, M.M. Backonja.
Anticonvulsionants for neuropathic pain syndromes: Mechanism of action and place in therapy.
Drugs, 60 (2000), pp. 1029-1052
[2.]
J. López-Trigo, J. Sancho.
Pregabalina: un nuevo tratamiento para el dolor neuropático.
Neurología, 21 (2006), pp. 96-103
[3.]
D.M. Tassone, E. Óbice, J. Guyer, D. Nuzum.
Pregabalin: A novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial onset seizures, and anxiety disorders.
[4.]
R.I. Henkin.
Drug induced taste and smell disorders.
Drug safety, 11 (1994), pp. 318-377
Copyright © 2010. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.